Fig. 6: The proposed mechanistic model underlying HIF-1α/NRP1-mediated VM in LUAD.

In tumor microenvironment, HIF-1α/NRP1 signaling can subsequently result in activation of MMP2, Vimentin, and VE-cadherin and thus promote EMT and VM, which ultimately contribute to tumor progression in LUAD.